Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study - Hanefeld, M; Marx, N; Pfützner, A (J Am Coll Cardiol, 2007)
et al.